ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma
Niklas Benedikt Pepper(University Hospital Münster), Walter Stummer(University of Münster), Stephan Rehn(University Hospital Münster), Michael Müther, Hans Theodor Eich(University Hospital Münster), Michael Oertel(Augenstern), Dorothee Cäcilia Spille(University Hospital Münster)
Cited by 19
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k